Breaking Barriers in Fertility: What Sets Tess Isabelle Cosad of Béa Fertility Apart

The femtech landscape is often dominated by clinical jargon and high-cost interventions.

Tess Isabelle Cosad, co-founder and CEO of Béa Fertility, wanted to change that with Béa Fertility. 

With her company, Cosad wanted to center clarity, compassion, and a relentless drive to democratize reproductive care. 

Today, she is reimagining how fertility support can look and feel, replacing sterile clinics with warm and welcoming care. In 2020, the global FemTech Market was valued at $40.2 billion. By 2025, it’s expected to reach $75.1 billion.

Where there’s money, there is (finally) interest. 

While many founders in this space chase technological complexity or VC buzzwords, Cosad is diligently focused on what really matters. This is why Béa Fertility prioritizes making meaningful, affordable, and inclusive fertility care available to those who’ve been overlooked by the traditional, under-funded system.

Tess Isabelle Cosad courtesy of the Conduit Connect

The Fertility Space Was (Is?) Broken 

While money is finally beginning to trickle out for women’s health issues, the system has lots of broken or else entirely undeveloped parts. 

We all know that men’s healthcare is overfunded (ahem, bentcarrot.com) and that the opposite is true for women’s care. While men can (finally) address the curvature in their reproductive organs, women’s health is still considered “niche”.

The fertility care industry is also broken, which was the initial inspiration for Cosa. Families desperately seeking care they cannot access or afford had nowhere to turn to fulfill their dreams of having a family. 

Enter Béa Fertility

Béa Fertility created a personalized fertility treatment plan that can be done in the comfort of one’s home. 

This fertility plan includes:

  • Clinician-led private consultations

  • A personalized treatment plan that helps plan cycles

  • An intracervical insemination kit, which includes 2 applicators per cycle

  • Continuous priority care and support from the Béa team. 

For those looking to explore a self-directed approach, Béa also offers 1-cycle and 3-cycle fertility kits. As they grow, the Béa team also centers their research. This allows them to improve their advice, approach, and research-driven treatments. To that end, Béa fertility has an efficacy rate of 39.28% pregnancy rate over 3 cycles. 

Championing Underrepresented Narratives

Tess’s vision for fertility care isn’t limited to the conventional paths. 

Where the traditional fertility industry often centers heterosexual, partnered couples with financial means, Cosad has always had a broader, more inclusive lens. 

Béa Fertility doesn’t limit their services to the “traditional” family model. They serve:

  • Single parents by choice

  • LGBTQ+ families

  • People living in underserved communities

  • Anyone (and everyone) who simply doesn’t fit into the narrow models that mainstream clinics cater to

This isn’t performative inclusion, either. It’s baked into the DNA of the brand. Their language, imagery, and product accessibility demonstrates that they are for everyone. This inclusivity is present at the corporate level too. Built during lockdown, the Béa team remains remote, which creates flexibility for employees and their families. 

Cosad explains that being remote, “has allowed us to hire from across the UK and beyond, think more globally and be more creative in how we manage being a remote team.”

Cosad’s commitment to equity in healthcare isn’t just aspirational, it’s operational. 

While access to fertility care is seen as a luxury, too many people are quietly navigating fertility struggles with no support. 

By building a company around these overlooked narratives, she’s changing not just the conversation, but the market too. Finally, families looking to start their dream family aren’t met with the closed door of a doctor’s office or an investment of tens of thousands of dollars. 

User-Centered Design in a Clinical Space

From the start, Béa Fertility has been grounded in user research, empathy, and real-world experience. 

Its at-home intracervical insemination (ICI) kit is a masterclass in design thinking. It reduces a complex clinical process into something safe, effective, intuitive, and (to be honest) elegant. 

Medical products are often designed for practitioners, not patients.

Béa’s kit is designed to empower, not intimidate. Everything from the packaging to the instructions speaks with clarity, warmth, and respect for this deeply personal journey. There’s no confusing terminology, no cold visuals, and (speaking of cold) no metal instruments. 

This kind of design-first, user-led approach is still surprisingly rare in fertility care. Cosad is helping to set a new standard for what medical devices should look like when they’re made with people in mind. 

A New Model for Femtech Leadership

There’s a growing appetite for authentic, mission-driven leadership in the femtech space, and Cosad is boldly answering the call. 

She’s candid about the realities of building a company in a historically underfunded and often undervalued category. She speaks openly about the systemic and cultural barriers to reproductive care. 

And she’s not afraid to challenge the status quo, even when it’s uncomfortable.

Under her leadership, Béa isn’t just a product company, it’s a platform for change. 

From clinical partnerships to open access resources, from diverse hiring practices to public education, Cosad is shaping a brand that stands for more than just profit. In a world where women’s health is being restricted and research is being ripped away, Tess Isabelle Cosad is 

We <3 Revolutionary femtech

Tess Isabelle Cosad is quietly revolutionizing fertility care. She’s not doing it with flashy tech or billion-dollar valuations or trips to outer space. Instead, understanding how deeply personal this journey can be, she approaches everything with heart, clarity, and purpose. 

She’s showing that reproductive care can be beautifully designed, radically inclusive, and truly empowering.

In a world where medical solutions often come with strings, stigma, or a steep price tag, Cosad is offering something rare: real agency. 

And that might be the most transformative innovation of all.

At Carter House Copy, we love FemTech startups that don’t stop at creating a revolutionary product. Founders like Tess Isabelle Cosad work to superpower the revolution that necessitated the product in the first place. 

At Carter House Copy, we’re more than a marketing agency. 

We want to be your partner. We want to break barriers and make a real impact with you. If you give us a call, we’ll bring the sledgehammer.

Next
Next

How Roma Van Der Walt is the Entrepreneurial Quintuple Threat (at Least)